Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus FSH versus letrozole plus HMG for ovulation induction in women with anovulatory infertility
IRCT201703153950N6Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of letrozole, follicle-stimulating hormone and human menopausal gonadotrophin in female infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
letrozolefollicle-stimulating hormonehuman menopausal gonadotrophin
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT201703153950N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201703153950N6.